ERNA - Eterna Therapeutics Inc.
0.285
-0.022 -7.719%
Share volume: 501,811
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.31
-0.02
-0.07%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 03-12-2025 | 05-07-2025 | 08-13-2025 | 11-07-2025 | |
| Assets | |||||
| Total Assets | 5.269 M | 5.059 M | 7.584 M | 6.172 M | |
| Current Assets | 2.352 M | 2.211 M | 4.792 M | 3.379 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.729 M | 1.918 M | 4.315 M | 3.047 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 85.000 K | 67.000 K | 50.000 K | 92.000 K | |
| Other Assets | 2.832 M | 2.781 M | 2.742 M | 2.701 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 5.269 M | 5.059 M | 7.584 M | 6.172 M | |
| Total liabilities | 3.568 M | 11.009 M | 3.140 M | 2.602 M | |
| Total current liabilities | 2.938 M | 10.438 M | 2.651 M | 2.144 M | |
| Accounts Payable | 1.721 M | 1.275 M | 1.319 M | 958.000 K | |
| Other liabilities | 630.000 K | 571.000 K | 489.000 K | 458.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 630.000 K | 571.000 K | 489.000 K | 458.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.700 M | -5.951 M | 4.443 M | 3.569 M | |
| Common stock | 233.236 M | 233.787 M | 247.328 M | 247.695 M | |
| Retained earnings | -231.536 M | -239.738 M | -242.885 M | -244.126 M |